First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial
Second-Line Tovecimig Elicits Responses in Biliary Tract Cancer
Tagrisso May Improve Survival in Advanced EGFR-Mutant NSCLC
Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care